Characterization of natural killer and antibody-dependent cellular cytotoxicity of preterm infants against human immunodeficiency virus-infected cells

Pediatric Research

Volumn 40, Issue 3, 1996, Pages 498-503

  Merrill, Jeffrey D ^a,c   Sigaroudinia, Mahvash ^a   Kohl, Steve ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 12;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CHROMIUM 51 RELEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEWBORN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029787143     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199609000-00021     Document Type: Article

References (36)

1. Newell ML, Dunn D, Peckham CS, Ades AE, Pardi G, Semprini AE 1992 Risk factors for mother-to-child transmission of HIV-1. European Collaborative Study [see comments]. Lancet 339:1007-1012
2. Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M, Hutson D, Grimm K, Kaul A, Bateman D, Rogers M 1995 Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group. Pediatrics 96:451-458
3. Uksila J, Lassila O, Hirvonen T 1982 Natural killer cell function of human neonatal lymphocytes. Clin Exp Immunol 48:649-654
4. Ueno Y, Miyawaki T, Seki H, Matsuda A, Taga K, Sato H, Taniguchi N 1985 Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development. J Immunol 135:180-184
5. Sancho L, de la Hera A, Casas J, Vaquer S, Martinez C, Alvarez MM 1991 Two different maturational stages of natural killer lymphocytes in human newborn infants. J Pediatr 119:446-454
6. Nair MP, Schwartz SA, Menon M 1985 Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and Interferon in neonates. Cell Immunol 94:159-171
7. McDonald T, Sneed J, Valenski WR, Dockter M, Cooke R, Herrod HG 1992 Natural killer cell activity in very low birth weight infants. Pediatr Res 31:376-380
8. Yabuhara A, Kawai H, Komiyama A 1990 Development of natural killer cytotoxicity during childhood: marked increases in number of natural killer cells with adequate cytotoxic abilities during infancy to early childhood. Pediatr Res 28:316-322
9. Uksila J, Lassila O, Hirvonen T, Toivanen P 1983 Development of natural killer cell function in the human fetus. J Immunol 130:153-156
10. Baley JE, Schacter BZ 1985 Mechanisms of diminished natural killer cell activity in pregnant women and neonates. J Immunol 134:3042-3048
11. Kohl S, Loo LS, Gonik B 1984 Analysis in human neonates of defective antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected cells. J Infect Dis 150:14-19
12. Leibson PJ, Hunter LM, Douvas GS, Hayward AR 1986 Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines. J Clin Immunol 6:216-224
13. Kunitomi T, Takigawa H, Sugita M, Nuono S, Suemune M, Inue M, Kodani N, Oda M, Ikeda M 1990 Antibody-dependent cellular cytotoxicity and natural killer activity against HTLV-1 infected cells. Acta Paediatr Jpn 32:16-19
14. Jenkins M, Mills J, Kohl S 1993 Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults. Pediatr Res 33:469-474
15. Erkeller YF, Deneys V, Yuksel B, Hannet I, Hulstaert F, Hamilton C, Mackinnon H, Stokes LT, Munhyeshuli V, Vanlangendonck F, De Bruyere M, Bach BA, Lydyard PM 1992 Age-related changes in human blood lymphocyte subpopulations. J Pediatr 120:216-222
16. Kohl S 1983 Defective infant antiviral cytotoxicity to herpes simplex virus-infected cells. J Pediatr 102:885-888
17. Potter CG, Potter AC 1988 A rapid and ultra-simplified method for separating lymphocytes from blood. J Immunol Methods 112:143-144
18. Blumberg RS, Paradis T, Hartshorn KL, Vogt M, Ho DD, Hirsch MS, Leban J, Sato VL, Schooley RT 1987 Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus. J Infect Dis 156:878-884
19. Lau AS, Sigaroudinia M, Yeung M, Kohl S 1994 Interleukin-12 (IL-12) induces interferon-gamma (IFN-gamma) expression and natural killer (NK) cell activity in cord blood mononuclear cells (MC). Pediatr Res 35:300A(abstr)
20. Rappocciolo G, Toso JF, Torpey DJ, Gupta P, Rinaldo C 1989 Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus. J Clin Microbiol 27:41-48
21. Goicoa MA, Sen L, Iannitelli PS, Diez RA, Estevez ME 1995 Natural killer suppressor factors in sera from HIV-infected subjects. Scand J Immunol 41:523-528
22. Cauda R, Tumbarello M, Ortona L, Kanda P, Kennedy RC, Chanh TC 1988 Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides. Cell Immunol 115:57-65
23. Harris DT, Cianciolo GJ, Snydcrman R, Argov S, Koren HS 1987 Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E. J Immunol 138:889-894
24. Sirianni MC, Tagliaferri F, Aiuti F 1990 Pathogenesis of the natural killer cell deficiency in AIDS. Immunol Today 11:81-82
25. Vivier E, Morin P, O'Brien C, Druker B, Schlossman SR, Anderson P 1991 Tryosine phosphorylation of the Fc gamma RIII (CD16): zeta complex in human natural killer cells. J Immunol 146:206-210
26. Bonnema JD, Kamitz LM, Schoon RA, Abraham RT, Leibson PJ 1994 Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J Exp Med 180:1427-1435
27. Payne NR, Frestedt J, Hunkeler N, Gehrz R 1993 Cell-surface expression of immunoglobulin G receptors on the polymorphonuclear leukocytes and monocytes of extremely premature infants. Pediatr Res 33:452-457
28. Gatti G, Cavallo R, Sartori ML, del PD, Masera R, Salvadori A, Carignola R, Angeli A 1987 Inhibition by cortisol of human natural killer (NK) cell activity. J Steroid Biochem 26:49-58
29. Holbrook NJ, Cox WI, Horner HC 1983 Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res 43:4019-4025
30. Murthy KK, Moya FR 1994 Effect of betamethasone on maternal, fetal and neonatal rat cellular immunity. Early Hum Dev 36:1-11
31. Lazzarin A, Luerti M, Capsoni F, Galli M, Uberti-Foppa C, Zavattini G, Corbella E 1986 A study of cellular immunity in newborns after prevention of Respiratory Distress Syndrome (RDS). Int J Tissue React 8:157-165
32. Wilson CB, Lewis DB 1990 Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev Infect Dis 12(suppl 4):S410-S420
33. Wu CY, Demeure C, Kiniwa M, Gately M, Delespesse G 1993 IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J Immunol 151:1938-1949
34. Scott ME, Kubin M, Trinchieri G, Kohl S 1995 Neonatal competence for Interleukin-12 (IL12) production. J Pediatr 37:285A(abstr)
35. Suen Y, Lee SM, Chang L, Knoppel E, van de Yen C, Cairo MS 1995 Decreased IL-12 and IFN-γ production from neonatal mononuclear cells (MNC): implication in the immaturity of neonatal cellular immunity. J Pediatr 37:286A(abstr)
36. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Lianes C, Kobayashi M, Perussia B, Young D, Nickbarg E, Wolf SF, Trinchieri G 1992 Natural killer (NK) cell stimulatory factor increases the cytotoxicity activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 175:789-796